AstraZeneca has signed a research agreement worth more than $5 billion with Chinese drugmaker CSPC Pharmaceutical Group, the ...

An AstraZeneca spokeswoman said ... for many years a hub of the group’s research. The closure, while offset by the Cambridge investment, was ...

AstraZeneca will move 2,100 of its UK-based scientists, most of whom are currently scattered around Cambridge, into the center next year. The center cost $1.3 billion to build. When fully ...

After years of delays and rising costs, AstraZeneca has formally unveiled its $1 billion R&D facility in Cambridge ... could one day become a biotech hub to rival Boston and San Francisco in ...

It joins a cluster of businesses seeking to make Cambridge a hub for life sciences research ... which promotes business development in the city. AstraZeneca worked with Oxford University to ...

AstraZeneca Plc will invest £650 million ($827 million) into Britain, expanding its Cambridge base and building a vaccine manufacturing plant near Liverpool. The drug-maker, which partnered with ...

AstraZeneca announced the new facility in March as part of wider plans to invest £650m across the UK. This would be split into £450m for the Speke project and a further £200m for Cambridge ...

LONDON (Reuters) – AstraZeneca is closing ... for many years a hub of the group’s research. The closure, while offset by the Cambridge investment, was also a blow to the British government.